Contact us for free information or to start a free case review.
Patients who are taking Bextra® should be aware of the Bextra® complications that can develop as a result of this prescription pain reliever. Bextra® is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID) developed by Pfizer. Bextra® was approved by the FDA in November 2001 to treat the pain associated with osteoarthritis, rheumatoid arthritis, menstrual pain, and other chronic pain conditions.
Reports of Bextra® complications began shortly after this drug was approved by the FDA. Skin-related Bextra® complications have caused serious injury to a number of patients who have taken this drug. Stevens Johnson Syndrome is a serious skin condition which may be caused by Bextra® complications. This skin condition causes a severe inflammatory eruption of the skin and mucous membranes. Toxic epidermal necrolysis is another serious skin condition that can result from Bextra® complications. This condition causes a large portion of the skin to become intensely red and peel in much the same manner as a second degree burn would.
Due to these serious Bextra® complications, the FDA and Pfizer have begun negotiations over the inclusion of a black box warning on all Bextra® patient product information. The black box warning is the strongest warning the FDA can mandate, short of pulling a drug off the market completely. If a black box warning is approved, Pfizer would be required to outline serious skin related Bextra® complications on all written Bextra® information and read the warning aloud during all audio commercials.
Other serious Bextra® complications are related to cardiovascular and stroke risks. These Bextra® complications have been discovered in two different clinical trials involving patients recovering from coronary artery bypass surgery. The trial participants who had received Bextra® after undergoing heart surgery were twice as likely to experience serious and life threatening Bextra® complications. These Bextra® complications include: heart attack, stroke, heart failure, deep venous thrombosis (blood clot), pulmonary embolism (blood clot in the lungs), renal dysfunction and failure, and delayed surgical healing.
These Bextra® complications are similar to the serious risks associated with other drugs similar to Bextra®. celebrex® studies have found that patients taking higher doses of this pain medication are more than twice as likely to suffer heart attack or stroke. Vioxx® was pulled off the market in September 2004, after studies indicated that patients taking Vioxx® for more than eighteen months doubled their risk of heart attack or stroke. These findings suggest that Bextra® complications may actually be common to all COX-2 selective pain medications.
In addition to these serious Bextra® complications, Bextra® use has also been associated with a number of other side effects. Other Bextra® complications include: gastrointestinal problems, unexplained weight gain, swelling, high blood pressure, jaundice, flu like symptoms, and general fatigue.
If you or a loved one has experienced Bextra® complications, you may wish to contact a qualified and experienced attorney who can help determine your legal rights and options in a case to seek relief for your injuries.
Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.
Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...
The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...
After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.